Literature DB >> 3390902

Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis.

J Lakatos1, A Hárságyi.   

Abstract

Patients with rheumatoid arthritis are at risk of increased prevalence of coronary heart disease. In general, the plasma level of high density lipoprotein cholesterol (HDL) correlates with the risk of incidence of ischemic heart disease. The levels of total, HDL, low density (LDL) cholesterol, and triglycerides were measured in sera of patients with rheumatoid arthritis and in healthy controls. In patients with rheumatoid arthritis (26 men and 103 women), the serum total and LDL cholesterol were higher, whereas the HDL cholesterol and triglycerides were lower (p less than 0.001) compared to the values observed in controls (625 men and 749 women). Similar patterns were seen when results of age and sex matched controls were compared to the results of patients suffering from rheumatoid arthritis. The lipid parameters of patients with rheumatoid arthritis were not different when the patients were treated with steroidal or nonsteroidal anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3390902     DOI: 10.1016/s0009-9120(88)80094-8

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  24 in total

Review 1.  Brain-immune interactions and the neural basis of disease-avoidant ingestive behaviour.

Authors:  Gustavo Pacheco-López; Federico Bermúdez-Rattoni
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-12       Impact factor: 6.237

Review 2.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm.

Authors:  Jamie Robertson; Mike J Peters; Iain B McInnes; Naveed Sattar
Journal:  Nat Rev Rheumatol       Date:  2013-06-18       Impact factor: 20.543

4.  Dyslipidemia and rheumatoid arthritis.

Authors:  R D Situnayake; G Kitas
Journal:  Ann Rheum Dis       Date:  1997-06       Impact factor: 19.103

Review 5.  [T cell-dependent monocyte activation, TNFalpha and apolipoprotein A-I in autoimmunity and inflammation].

Authors:  M Rossol; H Häntzschel; U Wagner
Journal:  Z Rheumatol       Date:  2005-05       Impact factor: 1.372

6.  Anti-arthritic effect of GN1, a novel synthetic analog of glucosamine, in the collagen-induced arthritis model in rats.

Authors:  Huma Jawed; Shazia Anjum; Shahid I Awan; Shabana U Simjee
Journal:  Inflamm Res       Date:  2011-08-27       Impact factor: 4.575

7.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

8.  Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity.

Authors:  G Vaudo; S Marchesi; R Gerli; R Allegrucci; A Giordano; D Siepi; M Pirro; Y Shoenfeld; G Schillaci; E Mannarino
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

9.  Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice.

Authors:  F Liao; A Andalibi; F C deBeer; A M Fogelman; A J Lusis
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

10.  Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation.

Authors:  Dursun Dursunoğlu; Harun Evrengül; Bülent Polat; Halil Tanriverdi; Veli Cobankara; Asuman Kaftan; Mustafa Kiliç
Journal:  Rheumatol Int       Date:  2004-07-31       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.